Estradiol hexahydrobenzoate

Chemical compound From Wikipedia, the free encyclopedia

Estradiol hexahydrobenzoate

Estradiol hexahydrobenzoate (EHHB), sold under a number of brand names including Benzo-Ginoestril A.P., BenzoGynoestryl Retard, Ginestryl-15-Depot, Menodin, and Tardoginestryl, is an estrogen medication which was previously used for indications such as menopausal hormone therapy and gynecological disorders.[1][2][3][4][5] EHHB is given by injection into muscle at regular intervals, for instance once every few weeks.[3][5][6][7]

Quick Facts Clinical data, Trade names ...
Estradiol hexahydrobenzoate
Thumb
Clinical data
Trade namesBenzo-Ginoestril A.P., BenzoGynoestryl Retard, Ginestryl-15-Depot, Menodin, Tardoginestryl
Other namesEHHB; Estradiol cyclohexanecarboxylate; ECHC; Oestradiol hexahydrobenzoate; Estradiol 17β-hexahydrobenzoate; Estradiol 17β-cyclohexanecarboxylate; Estradiol hexabenzoate
Routes of
administration
Intramuscular injection
Drug classEstrogen; Estrogen ester
Identifiers
  • (3-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl) cyclohexanecarboxylate
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
ECHA InfoCard100.035.623
Chemical and physical data
FormulaC25H34O3
Molar mass382.544 g·mol−1
3D model (JSmol)
  • CC12CCC3C(CCc4cc(O)ccc34)C1CCC2OC(=O)C5CCCCC5
  • InChI=1S/C25H34O3/c1-25-14-13-20-19-10-8-18(26)15-17(19)7-9-21(20)22(25)11-12-23(25)28-24(27)16-5-3-2-4-6-16/h8,10,15-16,20-23,26H,2-7,9,11-14H2,1H3
  • Key:IVRCALGRJCHPRV-UHFFFAOYSA-N
Close

Side effects of EHHB include breast tenderness, breast enlargement, nausea, headache, and fluid retention.[8] EHHB is an estrogen and hence is an agonist of the estrogen receptor, the biological target of estrogens like estradiol.[9][10] It is an estrogen ester and a prodrug of estradiol in the body.[10][9] Because of this, it is considered to be a natural and bioidentical form of estrogen.[10]

EHHB was first described in 1956,[11][12] and was introduced for medical use by 1957.[6] It was used in France.[6] The medication should not be confused with estradiol benzoate (EB), which has been marketed under similar brand names including Benzo-Ginestryl, Benzo-Ginoestril, and Benzo-Gynoestryl.[3][6][13]

Medical uses

EHHB was marketed in France in a 5 mg/mL oil solution in ampoules for intramuscular injection at regular intervals, for instance once every few weeks.[3][5][6][7] Use of EHHB for feminizing hormone therapy in transgender women has been reported.[14] A combination of 3 mg EHHB, 75 mg hydroxyprogesterone caproate, and 100 mg testosterone hexahydrobenzoate in 2 mL oil solution provided in ampoules has been marketed under the brand name Trinestril AP in Brazil.[15][16][17] Its indications include menopausal hormone therapy and the treatment of functional uterine bleeding.[15] The combination is administered typically once per month by intramuscular injection.[15]

Pharmacology

Thumb
Estradiol, the active form of EHHB.

Pharmacodynamics

EHHB is an estradiol ester, or a prodrug of estradiol.[10][9][18] As such, it is an estrogen, or an agonist of the estrogen receptors.[10][9] EHHB is of about 40% higher molecular weight than estradiol due to the presence of its C17β cyclohexanecarboxylate ester.[1] Because EHHB is a prodrug of estradiol, it is considered to be a natural and bioidentical form of estrogen.[10]

Pharmacokinetics

A combination of EHHB and norgestrel as a combined injectable contraceptive reportedly has a duration of action of about 3 weeks.[19]

Chemistry

EHHB, also known as estradiol cyclohexanecarboxylate (ECHC) as well as estradiol 17β-hexahydrobenzoate or estradiol 17β-cyclohexanecarboxylate, is a synthetic estrane steroid and an estrogen ester.[1][2][3][4] It is specifically the C17β cyclohexanecarboxylate (hexahydrobenzoate) ester of estradiol.[1][2]

History

EHHB was first described and characterized in 1956.[11][12] It was developed in France.[11][12] The medication was introduced for medical use in France by 1957.[6] A publicized case report of a rapidly growing breast cancer tumor in a 53-year-old woman 10 days after initiation of therapy with 5 mg/month EHHB by intramuscular injection for hot flashes was published in 1962.[20][21][22] The woman died due to breast cancer 10 months after the diagnosis.[20][22]

Society and culture

Generic names

Estradiol hexahydrobenzoate is the generic name of the drug and its INNTooltip International Nonproprietary Name), while oestradiol hexahydrobenzoate is its BANMTooltip British Approved Name.[1][2][3][4] The medication is also known as estradiol cyclohexanecarboxylate (ECHC).[1][2][3][4]

Brand names

EHHB has been marketed under the brand names Benzo-Ginoestril A.P., BenzoGynoestryl Retard, Ginestryl-15-Depot, Menodin, and Tardoginestryl.[1][2][3][4][5]

Availability

EHHB was previously marketed in France.[6]

Research

A combination of 5 mg EHHB in peanut oil solution and 25 mg norgestrel in aqueous suspension as a once-monthly combined injectable contraceptive was studied, but this formulation was ultimately never marketed.[23][24][25][26][27][19]

References

Loading related searches...

Wikiwand - on

Seamless Wikipedia browsing. On steroids.